Funding for this research was provided by:
german federal joint committee (01VSF16023)
Received: 28 June 2021
Accepted: 26 July 2021
First Online: 23 August 2021
: The ethics committee of the Hamburg chamber of physicians approved the study protocol (PV54565).
: DLR, TS, LL, LK, and MH have nothing to report. CG reports personal fees from Amgen, Bayer Vital, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi Aventis, Abbott, and Prediction Biosciences outside the submitted work. GT reports receiving consulting fees from Acandis, grant support, and lecture fees from Bayer, lecture fees from Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, and Daiichi Sankyo, and consulting fees and lecture fees from Stryker outside the submitted work.